Literature DB >> 12462403

Gene expression profiles of cholinergic nucleus basalis neurons in Alzheimer's disease.

Elliott J Mufson1, Scott E Counts, Stephen D Ginsberg.   

Abstract

Cholinergic neurons of the nucleus basalis (NB) are selectively vulnerable in Alzheimer's disease (AD), yet the molecular mechanisms associated with their dysfunction remain unknown. We used single cell RNA amplification and custom array technology to examine the expression of functional classes of mRNAs found in anterior NB neurons from normal aged and AD subjects. mRNAs encoding neurotrophin receptors, synaptic proteins, protein phosphatases, and amyloid-related proteins were evaluated. We found that trkB and trkC mRNAs were selectively down-regulated in NB neurons, whereas p75NTR mRNA levels remained stable in end stage AD. TrkA mRNA was reduced by approximately 28%, but did not reach statistical significance. There was a down-regulation of synaptophysin, synaptotagmin, and protein phosphatases PP1alpha and PP1beta mRNAs in AD. In contrast, we found a selective up-regulation of cathepsin D mRNA in NB neurons in AD brain. Thus, anterior NB neurons undergo selective alterations in gene expression in AD. These results may provide clues to the molecular pathogenesis of NB neuronal degeneration during AD.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12462403     DOI: 10.1023/a:1020952704398

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  92 in total

Review 1.  Genetics of synaptic vesicle function: toward the complete functional anatomy of an organelle.

Authors:  R Fernández-Chacón; T C Südhof
Journal:  Annu Rev Physiol       Date:  1999       Impact factor: 19.318

Review 2.  Distribution and retrograde transport of trophic factors in the central nervous system: functional implications for the treatment of neurodegenerative diseases.

Authors:  E J Mufson; J S Kroin; T J Sendera; T Sobreviela
Journal:  Prog Neurobiol       Date:  1999-02       Impact factor: 11.685

3.  A gene expression profile of Alzheimer's disease.

Authors:  J F Loring; X Wen; J M Lee; J Seilhamer; R Somogyi
Journal:  DNA Cell Biol       Date:  2001-11       Impact factor: 3.311

4.  Neuron-specific age-related decreases in dopamine receptor subtype mRNAs.

Authors:  Scott E Hemby; John Q Trojanowski; Stephen D Ginsberg
Journal:  J Comp Neurol       Date:  2003-02-03       Impact factor: 3.215

5.  Increased neuronal endocytosis and protease delivery to early endosomes in sporadic Alzheimer's disease: neuropathologic evidence for a mechanism of increased beta-amyloidogenesis.

Authors:  A M Cataldo; J L Barnett; C Pieroni; R A Nixon
Journal:  J Neurosci       Date:  1997-08-15       Impact factor: 6.167

6.  Around the WORLD backward: an algorithm for scoring the MMSE WORLD item.

Authors:  L A Beckett; R S Wilson; D A Bennett; M C Morris
Journal:  Neurology       Date:  1997-06       Impact factor: 9.910

Review 7.  Analysis of message expression in single neurons of Alzheimer's disease brain.

Authors:  L M Callahan; N Chow; J E Cheetham; C Cox; P D Coleman
Journal:  Neurobiol Aging       Date:  1998 Jan-Feb       Impact factor: 4.673

8.  Selective loss of central cholinergic neurons in Alzheimer's disease.

Authors:  P Davies; A J Maloney
Journal:  Lancet       Date:  1976-12-25       Impact factor: 79.321

9.  Interrater reliability of the NIH stroke scale.

Authors:  L B Goldstein; C Bertels; J N Davis
Journal:  Arch Neurol       Date:  1989-06

10.  Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment.

Authors:  Steven T DeKosky; Milos D Ikonomovic; Scot D Styren; Laurel Beckett; Stephen Wisniewski; David A Bennett; Elizabeth J Cochran; Jeffrey H Kordower; Elliott J Mufson
Journal:  Ann Neurol       Date:  2002-02       Impact factor: 10.422

View more
  51 in total

1.  Microarray analysis of CA1 pyramidal neurons in a mouse model of tauopathy reveals progressive synaptic dysfunction.

Authors:  Melissa J Alldred; Karen E Duff; Stephen D Ginsberg
Journal:  Neurobiol Dis       Date:  2011-11-07       Impact factor: 5.996

Review 2.  Expression profile analysis of neurodegenerative disease: advances in specificity and resolution.

Authors:  Jason G Glanzer; Phillip G Haydon; James H Eberwine
Journal:  Neurochem Res       Date:  2004-06       Impact factor: 3.996

3.  Gene expression profiling in fetal, aged, and Alzheimer hippocampus: a continuum of stress-related signaling.

Authors:  Walter J Lukiw
Journal:  Neurochem Res       Date:  2004-06       Impact factor: 3.996

4.  Single molecule transcription profiling with AFM.

Authors:  Jason Reed; Bud Mishra; Bede Pittenger; Sergei Magonov; Joshua Troke; Michael A Teitell; James K Gimzewski
Journal:  Nanotechnology       Date:  2007-05-09       Impact factor: 3.874

Review 5.  Single-cell and regional gene expression analysis in Alzheimer's disease.

Authors:  Ruby Kwong; Michelle K Lupton; Michal Janitz
Journal:  Cell Mol Neurobiol       Date:  2012-01-22       Impact factor: 5.046

Review 6.  Microarrays and the microscope: balancing throughput with resolution.

Authors:  Giovanni Coppola; Daniel H Geschwind
Journal:  J Physiol       Date:  2006-06-29       Impact factor: 5.182

Review 7.  Single cell gene expression profiling in Alzheimer's disease.

Authors:  Stephen D Ginsberg; Shaoli Che; Scott E Counts; Elliott J Mufson
Journal:  NeuroRx       Date:  2006-07

Review 8.  Genetics, transcriptomics, and proteomics of Alzheimer's disease.

Authors:  Andreas Papassotiropoulos; Michael Fountoulakis; Travis Dunckley; Dietrich A Stephan; Eric M Reiman
Journal:  J Clin Psychiatry       Date:  2006-04       Impact factor: 4.384

Review 9.  Aging of the brain, neurotrophin signaling, and Alzheimer's disease: is IGF1-R the common culprit?

Authors:  Luigi Puglielli
Journal:  Neurobiol Aging       Date:  2007-02-20       Impact factor: 4.673

Review 10.  Amyloid-Beta and Phosphorylated Tau Accumulations Cause Abnormalities at Synapses of Alzheimer's disease Neurons.

Authors:  Ravi Rajmohan; P Hemachandra Reddy
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.